Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy (2019)
Update date:2022-08-11
Topics:
Zhao, Baojuan
Wang, Minzhen
Wang
Yu, Pengfei
Wang, Na
Li, Fengjuan
A series of novel porphyrin-cinnamic acid (porphyrin/CA) conjugates (4a-4c) have been synthesized by condensation of 5-(4-Hydroxyphenyl)-10,15,20-triphenyl- porphyrin (1) with different substituted cinnamic acids (CAs) through an alkyl linker due to the biological activities of CAs and the application of porphyrins in photodynamic therapy (PDT) of cancer. Their related zinc (II) complexes (5a-5c) were also prepared. These novel compounds have been fully characterized by 1H NMR, Infrared (IR), Mass spectra (Ms) and Elemental analysis. The photophysical properties of these target molecules were studied by absorption and Fluorescence spectroscopy. In solution, the effect of pH, ionic strength in acid media and concentration on the aggregation behaviors of 4a has also been investigated by UV–Vis spectra. The broadened and red shifted Soret band indicated the formation of J-aggregates when the pH value was up to 2.0 in THF-aqueous solution. Furthermore, the higher ionic strength of 0.3 M NaCl in acid media resulted in the generation of J-aggregates in THF-aqueous solution. And the significant blue shift of Soret band also demonstrated the formation of H-aggregates of 4a at 1.1 × 10?4 M in THF.
View MoreAnhui Redstar Pharmaceutical Corp., Ltd
Contact:+86-563-5120837
Address:Jingxian Industrial Development Zone, Anhui , China
VanderArk International Limited
Contact:86-10-82437576
Address:Qing He
Shanghai Maxchemco Chemical Industry Co., Ltd.
Contact:(86)21-51079223
Address:No.1305-8, B241, the Ecust Park, Huajing Road, Xuhui District, Shanghai
Yangzhou Zhongbao Pharmaceutical Co.,Ltd
Contact:+86-514-88290838
Address:Jiangsu Baoying county economic develpment zone in baoying avenue91
Jiangsu zhiyuan yiyao keji youxian gongsi
Contact:1806109762
Address:Jiangsu
Doi:10.1021/ja01164a055
(1950)Doi:10.1016/0040-4020(95)00384-K
(1995)Doi:10.1016/S0022-328X(00)92349-0
(1979)Doi:10.1055/s-2004-815410
(2004)Doi:10.1016/S0040-4020(99)00470-6
(1999)Doi:10.1021/acs.molpharmaceut.0c00917
(2021)